Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 May;34(5):468–472. doi: 10.1136/jcp.34.5.468

Clinical significance of "circulating fibrin monomers'.

E M Haselager, J Vreeken
PMCID: PMC493326  PMID: 7251889

Abstract

During the decade 1970-9 we investigated circulating fibrin monomers in 3293 patients. Fibrinaemia was determined by means of the ethanol gelation test (EGT). This was positive in 149 patients (4.5%) and was highly correlated with fibrogenal fibrin products. In many diseases the test was only transiently positive (1 or 2 days). However in patients with circulating fibrin monomers, demonstrable for more than 5 days (chronic fibrinaemia) malignant disease was associated in 63%. Chronic fibrinaemia occasionally preceded overt malignancy by a long period. Overall, only 10.8% of patients with malignant disease showed chronic fibrinaemia. The clinical symptoms most often associated with chronic fibrinaemia were those of venous thrombosis (42.8%) and abnormal bleeding (10.7%). Thromboembolism in the absence of malignant disease only occasionally showed short-term positive EGT and chronic fibrinaemia was never seen. Almost half (46.5%) of patients with chronic fibrinaemia had neither thromboembolic disease nor a haemorrhagic diathesis.

Full text

PDF
468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breen F. A., Jr, Tullis J. L. Ethanol gelation: a rapid screening test for intravascular coagulation. Ann Intern Med. 1968 Dec;69(6):1197–1206. doi: 10.7326/0003-4819-69-6-1197. [DOI] [PubMed] [Google Scholar]
  2. Davis R. B., Theologides A., Kennedy B. J. Comparative studies of blood coagulation and platelet aggregation in patients with cancer and nonmalignant diseases. Ann Intern Med. 1969 Jul;71(1):67–80. doi: 10.7326/0003-4819-71-1-67. [DOI] [PubMed] [Google Scholar]
  3. Godal H. C., Abildgaard U. Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol. 1966;3(5):342–350. doi: 10.1111/j.1600-0609.1966.tb02378.x. [DOI] [PubMed] [Google Scholar]
  4. Kierulf P., Godal H. C. Fibrinemia in medical patients screened by the ethanol test. Acta Med Scand. 1971 Sep;190(3):185–190. doi: 10.1111/j.0954-6820.1971.tb07414.x. [DOI] [PubMed] [Google Scholar]
  5. Kierulf P. Studies on soluble fibrin in plasma. 3. N-terminal analysis of a modified fraction I (Cohn) from plasmin- and thrombin-incubated plasma. Scand J Clin Lab Invest. 1973 Jan;31(1):43–49. doi: 10.3109/00365517309082417. [DOI] [PubMed] [Google Scholar]
  6. Kisker C. T., Rush R. Detection of intravascular coagulation. J Clin Invest. 1971 Nov;50(11):2235–2241. doi: 10.1172/JCI106720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  8. Lipinski B., Gurewich V., Nowak A., Wetmore R. The effect of heparin and dipyridamole on the deposition of fibrin-like material in rabbits infused with soluble fibrin monomer or fibrinogen. Thromb Res. 1974 Sep;5(3):343–358. doi: 10.1016/0049-3848(74)90172-8. [DOI] [PubMed] [Google Scholar]
  9. Lipinski B., Wegrzynowicz Z., Budzynski A. Z., Kopeć M., Latallo Z. S., Kowalski E. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):65–77. [PubMed] [Google Scholar]
  10. MOOLTEN S. E., VROMAN L. Role of blood platelets in thromboembolism. Arch Intern Med (Chic) 1949 Nov;84(5):667–710. doi: 10.1001/archinte.1949.00230050003001. [DOI] [PubMed] [Google Scholar]
  11. Miller S. P., Sanchez-Avalos J., Stefanski T., Zuckerman L. Coagulation disorders in cancer. I. Clinical and laboratory studies. Cancer. 1967 Sep;20(9):1452–1465. doi: 10.1002/1097-0142(196709)20:9<1452::aid-cncr2820200912>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  12. Müller-Berghaus G., Heinrich D. Fibrin monomer and platelet aggregation in vitro and in vivo. Br J Haematol. 1972 Aug;23(2):177–188. doi: 10.1111/j.1365-2141.1972.tb03471.x. [DOI] [PubMed] [Google Scholar]
  13. Müller-Berghaus G., Róka L., Lasch H. G. Induction of glomerular microclot formation by fibrin monomer infusion. Thromb Diath Haemorrh. 1973 May 10;29(2):375–383. [PubMed] [Google Scholar]
  14. Niewiarowski S., Gurewich V. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. J Lab Clin Med. 1971 Apr;77(4):665–676. [PubMed] [Google Scholar]
  15. O'MEARA R. A. Coagulative properties of cancers. Ir J Med Sci. 1958 Oct;394:474–479. [PubMed] [Google Scholar]
  16. O'MEARA R. A., THORNES R. D. Some properties of the cancer coagulative factor. Ir J Med Sci. 1961 Mar;423:106–112. doi: 10.1007/BF02952952. [DOI] [PubMed] [Google Scholar]
  17. Pineo G. F., Brain M. C., Gallus A. S., Hirsh J., Hatton M. W., Regoeczi E. Tumors, mucus production, and hypercoagulability. Ann N Y Acad Sci. 1974;230:262–270. doi: 10.1111/j.1749-6632.1974.tb14458.x. [DOI] [PubMed] [Google Scholar]
  18. Pineo G. F., Regoeczi E., Hatton M. W., Brain M. C. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med. 1973 Aug;82(2):255–266. [PubMed] [Google Scholar]
  19. Reinicke R., Matthias F. R., Lasch H. G. Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy. Thromb Res. 1977 Sep;11(3):365–375. doi: 10.1016/0049-3848(77)90188-8. [DOI] [PubMed] [Google Scholar]
  20. STRENGERS T., ASBERG E. G. EEN SCREENING-TEST, GEVOLGD DOOR EEN SNELLE KWANTITATIEVE MICROBEPALING VAN FIBRINOGEEN IN PLASMA. Ned Tijdschr Geneeskd. 1963 Nov 2;107:2044–2045. [PubMed] [Google Scholar]
  21. Sherman L. A. Fibrinogen turnover: demonstration of multiple pathways of catabolism. J Lab Clin Med. 1972 May;79(5):710–723. [PubMed] [Google Scholar]
  22. Slaastad R. A., Godal H. C. Coagulation profile and the ethanol gelation test with special reference to components consumed during coagulation. Scand J Haematol. 1976 Jan;16(1):25–32. doi: 10.1111/j.1600-0609.1976.tb01112.x. [DOI] [PubMed] [Google Scholar]
  23. Vreeken J., Van der Meer J., Fedder G., Van Aken W. G., Goote T. M. Chronic fibrinaemia as an indicator of a "prethrombotic state". Neth J Med. 1974;17(3):121–130. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES